Parkinson's, dementia
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
A report from radaronline.com indicates something that is worrying the US political environment, just days after the death of ...
Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's ...
Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...
While hearing loss has been associated with cognitive decline and considered a risk factor for dementia, this study, ...
Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...
A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...
Patients with ankylosing spondylitis are associated with an increased risk of developing neurodegenerative diseases, ...
Life takes its toll on our brains. Our brain cells pick up wear and tear over the years, causing our minds to become slower, ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in a adults with Parkinson’s disease whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback